Disrupting the APC-Asef Interaction Suppresses Cancer Cell Migration [Drug Design]

Structure-based design yields peptidomimetic APC–ARM pocket inhibitors that block Asef binding.
Source: Cancer Discovery - Category: Cancer & Oncology Tags: Drug Design Source Type: research